Back to results
US 9,435,743 B2Granted
Methods using a modified bacteriophage for the detection of target molecules
OwnerAlexey Gennadievich Zdanovskyinventor
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods and compositions for the detection of target molecules, comprising modified bacteriophages engineered to express a luciferase.
Claims10
A method for detecting a target molecule, comprising:
- a) contacting an immobilized target molecule with a modified bacteriophage comprising SEQ ID NO:
- 1, SEQ ID NO:2, SEQ ID NO:3, or SEQ ID NO:4, wherein the bacteriophage specifically binds the target molecule, under conditions that promote binding of the bacteriophage to the target molecule, to produce a target molecule-bacteriophage complex;
- b) contacting the target molecule-bacteriophage complex with a bacterial strain susceptible to infection by the bacteriophage;
- c) incubating the target molecule-bacteriophage complex with the bacterial strain under conditions that promote the propagation of the bacteriophage in the bacteria and expression of the luciferase, to produce a bacteriophage-infected culture;
- d) adding to the bacteriophage-infected culture a substrate for the luciferase;
- and
- e) measuring the presence and/or magnitude of fluorescence produced from the action of the luciferase on its substrate.
4 more elements
A method for detecting a target molecule, comprising:
- a) contacting an immobilized target molecule with a first affinity ligand that specifically binds the target molecule, under conditions that promote target molecule-affinity ligand binding, to form a target molecule-first affinity ligand complex, and optionally contacting the target molecule-first affinity ligand complex with one or more additional affinity ligands under conditions that promote affinity ligand-affinity ligand binding, to produce a target molecule-first affinity ligand-additional affinity ligand complex, wherein the one or more affinity ligands are added sequentially, and wherein each successive affinity ligand specifically binds to the affinity ligand added immediately previous;
- b) contacting the target molecule-first affinity ligand complex or the target molecule-first affinity ligand-additional affinity ligand complex with a modified bacteriophage comprising SEQ ID NO:
- 1, SEQ ID NO:2, SEQ ID NO:3, or SEQ ID NO:4, wherein the bacteriophage binds to the first affinity ligand, or if one or more additional affinity ligands are used, binds to the ultimate affinity ligand, to form a target molecule-affinity ligand-bacteriophage complex;
- c) contacting the target molecule-affinity ligand-bacteriophage complex with a bacterial strain susceptible to infection by the bacteriophage;
- d) incubating the target molecule-affinity ligand-bacteriophage complex with the bacterial strain under conditions that promote the propagation of the bacteriophage in the bacteria and expression of the luciferase, to produce a bacteriophage-infected culture;
- e) adding to the bacteriophage-infected culture a substrate for the luciferase;
- and
- f) measuring the presence and/or magnitude of fluorescence produced from the action of the luciferase on its substrate.
5 more elements
Dependencies are inferred from the claim text.